CDT Equity Delays Annual Report Filing
TipRanks (Wed, 1-Apr 8:03 PM ET)
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
Globe Newswire (Thu, 26-Mar 8:30 AM ET)
CDT Equity Inc. Announces Reverse Stock Split
Globe Newswire (Wed, 25-Mar 8:00 AM ET)
Globe Newswire (Mon, 23-Mar 8:30 AM ET)
Globe Newswire (Wed, 18-Mar 8:30 AM ET)
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
Globe Newswire (Thu, 12-Mar 8:30 AM ET)
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
Globe Newswire (Thu, 5-Mar 8:30 AM ET)
CDT Positions for Transformational Growth
Globe Newswire (Wed, 4-Mar 8:30 AM ET)
CDT’s Strategic Stake in Sarborg Unlocks AI-Driven Asset Potential and Scientific Synergies
Market Chameleon (Fri, 20-Feb 4:52 AM ET)
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
Globe Newswire (Fri, 20-Feb 8:30 AM ET)
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The group is committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.
CDT Equity trades on the NASDAQ stock market under the symbol CDT.
As of April 1, 2026, CDT stock price was flat at $5.10 with 93,935 million shares trading.
CDT has a beta of 3.56, meaning it tends to be more sensitive to market movements. CDT has a correlation of 0.21 to the broad based SPY ETF.
CDT has a market cap of $24.08 million. This is considered a Sub-Micro Cap stock.
CDT has underperformed the market in the last year with a price return of -99.8% while the SPY ETF gained +18.1%. CDT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -84.1% and -59.8%, respectively, while the SPY returned -3.6% and -0.7%, respectively.
CDT support price is $4.43 and resistance is $5.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CDT shares will trade within this expected range on the day.
